Pages

Thursday, December 26, 2013

Immune Pharmaceuticals: A Speculative Biotech Option For The Patient Investor

... the company's origins and research facilities are located in Israel, but the corporate headquarters are located in Tarrytown, New York. This has been the case for the company since late 2012, when Immune completed a reverse merger with the U.S. ...

http://seekingalpha.com/article/1917631-immune-pharmaceuticals-a-speculative-biotech-option-for-the-patient-investor?source=feed

No comments:

Post a Comment